

(Sharecast News) - Biotherapeutics developer Avacta Group announced on Monday that its joint venture with Daewoong Pharmaceutical, AffyXell Therapeuti...


IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test


IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma


(Sharecast News) - Cancer therapy and diagnostics developer Avacta Group has entered into a licence agreement with Point Biopharma, it announced on Th...


UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost


(Sharecast News) - Cancer therapy developer Avacta Group has submitted a clinical trial application in the UK for a phase 1 first-in-human open label ...


UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain


(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group has entered into a licensing agreement with Astrea Bioseparations, it annou...